These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12237241)

  • 1. The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients.
    Müller C; Hennig E; Franke C; Krahl R; Leiblein S; Niederwieser D; Deininger MW
    Cancer Genet Cytogenet; 2002 Jul; 136(2):149-50. PubMed ID: 12237241
    [No Abstract]   [Full Text] [Related]  

  • 2. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
    Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation.
    Hsu WT; Preisler H; Szego K; Sprudzs R; Gao XZ
    Cancer Genet Cytogenet; 1998 Jul; 104(1):57-60. PubMed ID: 9648560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia.
    Smoley SA; Brockman SR; Paternoster SF; Meyer RG; Dewald GW
    Cancer Genet Cytogenet; 2004 Jan; 148(1):1-6. PubMed ID: 14697634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
    Haigh S; Cuthbert G
    Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of bcr/abl fusion gene and its derivative chromosome 9 deletions in CML by using home-made bcr/abl extra-signal probe].
    Lai YY; Feng L; Wang Z; Lü S; Dang H; Shi Y; He Q; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):199-203. PubMed ID: 20137147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
    Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
    Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
    Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
    Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia.
    Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Saito M; Miura AB
    Cancer Genet Cytogenet; 1996 Jul; 89(2):166-9. PubMed ID: 8697426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR/ABL fusion gene detected on 9q34 by fluorescence in situ hybridization in an acute leukemia with two BCR/ABL positive clones, one Ph-negative and one Ph-positive.
    Terré C; Bastie JN; Garcia I; Suzan F; Cayuela JM; Therond P; Castaigne S
    Cancer Genet Cytogenet; 2001 Nov; 131(1):37-41. PubMed ID: 11734316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine fluorescence in situ hybridization analysis for detection of BCR-ABL rearrangement in myeloproliferative disorders.
    Sabatino G; Calabrese G; Guanciali Franchi P; Stuppia L; Jadayel D; Donti E; Palka G
    Leuk Res; 1997 Jun; 21(6):581-3. PubMed ID: 9279369
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of the BCR-ABL fusion: Comparative analysis of six commercially available FISH fusion probes].
    Knas T; Buck M; Stegelmann F; Möller P; Barth TF
    Pathologe; 2015 Jul; 36(4):372-84. PubMed ID: 26175197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia.
    Costa D; Espinet B; Queralt R; Carrió A; Solé F; Colomer D; Cervantes F; Hernández JA; Besses C; Campo E
    Cancer Genet Cytogenet; 2003 Mar; 141(2):114-9. PubMed ID: 12606128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases.
    Abruzzese E; Pettenati MJ; Cox K; Jackle B; Watts RG; Carroll AJ; Steuterman MC; Rao PN
    Cancer Genet Cytogenet; 1998 Sep; 105(2):164-7. PubMed ID: 9723035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.